Gene · 9401
Papers1,646
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,646
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel Germline Pathogenic Variant of RECQL4 Gene in an Iranian Pedigree with Familial Squamous Cell Carcinoma: A Brief Report. | Iran J Med Sci | 2023 | 37456212 | PubTator, text mining | PubMed |
| Lynch-like syndrome with germline WRN mutation in Bulgarian patient with synchronous endometrial and ovarian cancer. | Hered Cancer Clin Pract | 2023 | 37452354 | PubTator, text mining | PubMed |
| Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development. | Int J Mol Sci | 2023 | 37445641 | PubTator, text mining | PubMed |
| Characteristics of DNA macro-alterations in breast cancer with liver metastasis before treatment. | BMC Genomics | 2023 | 37434117 | PubTator, text mining | PubMed |
| DNA double-strand break genetic variants in patients with premature ovarian insufficiency. | J Ovarian Res | 2023 | 37430352 | PubTator, text mining | PubMed |
| Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy. | Anal Cell Pathol (Amst) | 2023 | 37426488 | PubTator, text mining | PubMed |
| PARP1 negatively regulates transcription of BLM through its interaction with HSP90AB1 in prostate cancer. | J Transl Med | 2023 | 37415147 | PubTator, text mining | PubMed |
| The hydrophilic extract from a new tomato genotype (named DHO) kills cancer cell lines through the modulation of the DNA damage response induced by Campthotecin treatment. | Front Oncol | 2023 | 37409248 | PubTator, text mining | PubMed |
| Molecular typing and mutational characterization of rectal neuroendocrine neoplasms. | Cancer Med | 2023 | 37387515 | PubTator, text mining | PubMed |
| Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models. | Front Oncol | 2023 | 37377921 | PubTator, text mining | PubMed |
| Uncharacterized Proteins CxORFx: Subinteractome Analysis and Prognostic Significance in Cancers. | Int J Mol Sci | 2023 | 37373333 | PubTator, text mining | PubMed |
| Genomic profiling, prognosis, and potential interventional targets in young and old patients with cholangiocarcinoma. | Cancer Biol Ther | 2023 | 37337460 | PubTator, text mining | PubMed |
| G-quadruplexes and associated proteins in aging and Alzheimer's disease. | Front Aging | 2023 | 37323535 | PubTator, text mining | PubMed |
| Var∣Decrypt: a novel and user-friendly tool to explore and prioritize variants in whole-exome sequencing data. | Epigenetics Chromatin | 2023 | 37312221 | PubTator, text mining | PubMed |
| New Functions of Intracellular LOXL2: Modulation of RNA-Binding Proteins. | Molecules | 2023 | 37298909 | PubTator, text mining | PubMed |
| Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications. | Int J Mol Sci | 2023 | 37298642 | PubTator, text mining | PubMed |
| Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in Cancer Stem Cells. | Int J Mol Sci | 2023 | 37298484 | PubTator, text mining | PubMed |
| Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival. | Ann Med | 2023 | 37272300 | PubTator, text mining | PubMed |
| Biochemical properties of naturally occurring human bloom helicase variants. | PLoS One | 2023 | 37267408 | PubTator, text mining | PubMed |
| Hereditary Breast Cancer in Romania-Molecular Particularities and Genetic Counseling Challenges in an Eastern European Country. | Biomedicines | 2023 | 37239058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9401/papers?page=9